Landscapes / Targets
EP4
4 drugs act on EP4, in 9 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs4
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
YY001not checked |
— |
Phase 3 | 1 Jun 2027Phase 3 trial completes | ||
| Next date | 1 Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Upper Limb Spasticity | ||||
| Open drug page | |||||
— |
Phase 3 | 15 Feb 2028Phase 2 trial completes | |||
| Next date | 15 Feb 2028 · Phase 2 trial completes | ||||
| Also tested for | Gastric Cancer, Colorectal Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Refractory Metastatic Colorectal Cancer, Solid Tumor and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jun 2027Phase 1/2 trial completes | |||
| Next date | Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Cytokine Release Syndrome | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 4 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026